Guardant Health
417 hedge funds and large institutions have $11.1B invested in Guardant Health in 2021 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 188 increasing their positions, 107 reducing their positions, and 62 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 188 | Existing positions reduced: 107
11% more call options, than puts
Call options by funds: $98M | Put options by funds: $88.6M
0% less funds holding
Funds holding: 419 → 417 (-2)
3% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 62
2.38% less ownership
Funds ownership: 90.99% → 88.6% (-2.4%)
20% less capital invested
Capital invested by funds: $13.9B → $11.1B (-$2.82B)
60% less funds holding in top 10
Funds holding in top 10: 10 → 4 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$180M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$110M |
| 3 |
Coatue Management
New York
|
+$86.5M |
| 4 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
+$68.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$750M |
| 2 |
Jennison Associates
New York
|
-$275M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$143M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$94.6M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$85.7M |
GH Hedge Fund Activity: Q2 2021 in Review
417 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q2 2021, worth a combined $11.1B — down 20% from $13.9B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of GH and 60 opened new positions — a net loss of 2 holders — while 107 trimmed existing stakes and 188 added.
The largest buyer was Viking Global Investors, adding an estimated $180M. The largest seller was SB Investment Advisers (UK), cutting an estimated $750M.
- 417 institutional investors held Guardant Health (GH) as of Q2 2021, down from 419 in Q1 2021.
- Funds reported $11.1B of Guardant Health stock for Q2 2021, down 20% quarter-over-quarter.
- 60 funds opened new Guardant Health positions in Q2 2021 and 62 closed out, a net change of -2 holders.
- The largest Guardant Health buyer in Q2 2021 was Viking Global Investors, an estimated $180M added.
- The largest Guardant Health seller in Q2 2021 was SB Investment Advisers (UK), an estimated $750M sold.
Based on aggregated 13F filings for Q2 2021.